Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
9.26
-1.07 (-10.36%)
Jan 29, 2026, 3:16 PM EST - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $73.67 million as of January 29, 2026. Its market cap has decreased by -59.16% in one year.
Market Cap
73.67M
Enterprise Value
139.97M
1-Year Change
-59.16%
Ranking
Category
Stock Price
$9.26
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $73.67M, a decrease of -78.10%. That is a compound annual growth rate of -25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 82.18M | 51.91% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 551.83M |
| Burning Rock Biotech | 387.81M |
| Prenetics Global | 324.62M |
| Insight Molecular Diagnostics | 197.50M |
| MDxHealth | 183.14M |
| FONAR | 122.18M |
| Exagen | 97.68M |
| Precipio | 42.92M |